In 1957 Dorfman and Lorincz first reported an excess and abnormal excretion of acidic glycosaminoglycans (AGAG) in a six-year-old girl with Hurler syndrome. Since then, the quantitative and qualitative studies on urinary AGAG in patients who were diagnosed as then so-called "Hurler syndrome" have been made by many investigators, and in 1966 McKusick proposed a classification of mucopolysac charidoses on the basis of the analytical data of the urinary AGAG and on clinical or genetic criteria in patients with Hurler syndrome.
Therefore the analysis of urinary AGAG is one of the most important procedures to make a differential diagnosis of mucopolysaccharidoses. of AGAG, and we want to designate this abnormality as "chondroitin 4-and 6-sulfaturia".
CASE RECORD
The patient Y.S., a 14-year-old boy, was a pupil of a special school for weak children. His I.Q. was 66. The family history revealed that his grandfather and grandmother on the father's side were first cousins. No other similarly affected persons have been known in this family. He began to walk without support at the age of 2 years.
At the age of 4 years he underwent an operation for right inguinal herniation; at the age of 5 years he was noted to have a limping gait and hospitalized for a month under the presumptive diagnosis of bilateral perthes disease. At the age of 8 years he entered the Hospital School for Handicapped Children in Koriyama City and received treatment of traction and no-weight bearing for 3 years. At that time he was suspected to have Morquio syndrome . However, the examination of urinary AGAG revealed no abnormal excretion of keratan sulfate . Since then he has been boarding in the School for Mentally Retarded Children , where he was noticed to be an excess excretor of chondroitin 4-and 6-sulfates .
Physical findings. The results of physical examination were as follows: a short boy 125 .2 cm tall and weighing 37.0 kg; short neck , pigeon breast, large lips and saddle nose, coarse facies, hypertrichosis, dorsolumbar scoliosis . No rales, no bronchial breathing nor hepatosplenomegaly was observed. The heart sound was normal . No joint abnormality was observed except at hip joints where limitation of movement and flexor contracture were found. The skin was not coarse . The examination of the eyes revealed normal cornea and fundi.
X-ray examination of the bones, the scapulae , hands, feet and long tubular bones showed no special findings except the femur. The heads of the bilateral femurs were flat , constituting coxa valga at the hip joints , and the rim of acetabulum was irregular. The spinal roentgenogram showed slight lumbar kyphosis and a slight dorsal dislocation of the 4th lumbar vertebra.
The lower thoracic and upper lumbar vertebral bodies have an anterior hook-like projection , so-called "beaking of the vertebra". Ethanol fractionation of the urinary AGAG. 530 mg of the crude AGAG obtained by the above-mentioned procedures was fractionated by fractional precipitation with different ethanol concentrations in the presence of calcium ion: one per cent solution of the sample was made in 5% calcium acetate-0.5 N acetic acid buffer and after removing the insoluble material AGAG was precipitated with 3 volumes of ethanol. The recovered AGAG was redissolved in the calcium acetate-acetate buffer and ethanol was added to give a final ethanol concentration of 25%. The precipitate (25% EtOH Fr.) was separated and dried with ethanol and ether. Ethanol was further added to the supernate obtained above to give a final concentration of 80%. The resultant precipitate (80% EtOH Fr.) was separated and dried. (Wessler 1971) . AGAG was located by staining with 1% toluidine blue followed by washing with 2% acetic acid.
On electrophoresis in 0.075 M barium acetate solution three bands, the fast-, the intermediate-and the slow-moving bands, are obtained, each band corresponding to chondroitin 4-/6-sulfates (Ch4-/6-S), DS and HS, respectively. AGAG content in each band was determined by colorimetric measurement according to Kimura et al. (1974) .
Differentiation of AGAG with enzymes. In order to specify the AGAG species the following enzymes were used: chondroitinase AC II, ehondroitinase ABC and Streptomyces hyaluronidase.
The enzymes were purchased from Seikagaku Kogyo Co., Ltd., Tokyo. AGAG which was not digested with specific enzymes was determined by electrophoresis.
The quantitative determination of chondroitin 4-or 6-sulfate was carried out by digestion with chondroitinase AC II and ABC according to the method of Saito et al. (1968) . The unsaturated disaccharides in the digest were separated by descending paper chromatography and estimated by spectrophotometry. Glucosamine and galactosamine contents were determined on an automatic amino acid analzyer (JLC-5AH, JEOL, Ltd ., Tokyo) after hydrolysis with 2 N HCl at 100°C for 14 hr.
RESULTS
As shown in Table 1 , the urinary excretion of AGAG in this patient was in the range of 30.2-73.1 mg/day, averaging 47.9 mg/day (as glucuronic acid). Electrophoresis of each crude fraction in 0.075 M barium acetate solution showed that the main component of the crude AGAG was Ch4-/6-S, which amounted to about 80% of total urinary AGAG.
For the further characterization of the urinary AGAG, eight crude AGAG frac tions obtained from 2nd and 3rd experiments were combined and used for the ethanol fractionation described above. The 80% EtOH Fr., containing 92.6% (Fig . 2) .
The 25% EtOH Fr. accounted for 7 .4% of total AGAG. About 40% of the 25 % EtOH Fr. was eluted with 1.5 M sodium chloride from a Dowex 1 column. The electrophoresis of the subfractions of the 25% EtOH Fr . showed the main com ponent of the 1.0 M fr. to be HS, and the other three fractions consisted of DS and HS (Fig. 3) . •õ Unsaturated disaccharides formed by chondroitinase AC II digestion.
OS: ƒ¢Di-0S; 4S: ƒ¢Di-4S; 6S: ƒ¢Di-6S; diS: ƒ¢Di-diS.
•ö Molar ratios based on hexosamine=1. Table 4 summarizes the quantitative distribution of the individual AGAG in this patient's urine. Ch4-S and Ch6-S, 40.3% and 38.8% of the total AGAG respectively, are the major urinary AGAG in this patient. HS and DS constitute 16.1% and 4.8% of the total amount of urinary AGAG respectively. Fig. 4 shows the molecular-weight distribution patterns of the urinary AGAG from normal subjects and the patient. The molecular sizes of the crude AGAG obtained from this patient were smaller than those from normal subjects. Elution patterns of the AGAG fractionated by Dowex 1 are shown in Fig. 5 and indicate that the molecular-weight distribution patterns of the 1.5 M fr. and 2.0 M fr. were similar to those of the crude AGAG of normal subjects . However, the molecular sizes of the 1.0 M fr. and 1.25 M fr. were smaller than those of the crude AGAG from normal urine.
DISCUSSION
Patients with abnormal acidic glycosaminoglycans metabolism have varying degrees of mental and physical retardation in conjunction with excessive urinary excretion of DS, HS and keratan sulfate. Hers (1965) suggested that the electron microscopic findings and natural history of the mucopolysaccharidoses were consistent with their being "lysosomal diseases". Neufeld and her colleagues showed that cells from several of the mucopolysaccharidoses have a defect in the degradation of mucopolysaccharides and that a diffusible factor produced by normal cells or by cells from a different mucopolysaccharidosis corrects this metabolic defect in vitro (Fratantoni et al. 1968 ). These and other advances showed that these mucopolysaccharidoses were caused by defect of lysosomal enzymes (Dorfman and Matalon 1976). Recently increased excretion of Ch4-S and/or Ch6-S has been noted in the pathological conditions by several authors. However, few reports on molecular characteristics of the excreted compounds are found. It may be difficult to find a biochemical abnormality from the excretion mode or chemical properties of these urinary AGAG, because Ch4-S and Ch6-S constitute the major AGAG in normal urine and are heterogeneous in molecular sizes and in sulfate content as mentioned above. but the major urinary AGAG was Ch4-S and Ch6-S which had a hybrid structure of uronic acid composition. In these patients with "chondroitin 4-/6-sulfaturia", however, the defect of a specific enzyme responsible for the abnormal metabolism of Ch4-/6-S has not been reported. 
